Notice ID: 07cb7d5e1b5c4f1c85c21dc21bbc6d1fAward NoticeAwardedArchived
SIRTEX SIR-Spheres Y-90 Microspheres
Awarded on August 19, 2026. Full description on SAM.gov.
Awarded tounder HT941026PE151 (source: SAM.gov award notice)• $23.4K
Overview
- Posted
- August 19, 2026
- Notice type
- Award Notice
- Set-aside
- No Set aside used
- NAICS
- 325412: Pharmaceutical Preparation Manufacturing
- Agency
- Department of WarDEFENSE HEALTH AGENCY (DHA)
Notice details
- Office
- DEFENSE HEALTH AGENCY HCD WEST
- Place of performance
- Washington, 98011
- Last updated
- Oct 28, 2026
- First published
- Last updated on SAM.gov
- Award date
- Aug 19, 2026
- Award amount (SAM.gov award notice)
- $23.4K
Identifiers
- Solicitation number
- HT941026PE151
- Notice ID
- 07cb7d5e1b5c4f1c85c21dc21bbc6d1f
- Award number (PIID)
- HT941026PE151
Description
Contract Award HT941026PE151 - SIRTEX SIR-Spheres Y-90 Microspheres
Award Overview
Award Number
HT941026PE151
Award Amount (SAM.gov award notice)
$23.4K
Award Date
Aug 19, 2026
Awardee
Awardee UEI
CWH2GM13A2V6
Awardee CAGE Code
45EE6
Awardee Address
Woburn, MA 01801, UNITED STATES
Original Solicitation
Notice ID: 07cb7d5e1b5c4f1c85c21dc21bbc6d1f
Posted Date: Aug 19, 2026
Original Response Deadline: Not specified
Contract Details
Contract data not yet available
Contract details typically appear within 2-4 weeks after award; DoD awards are published about 90 days after signature.
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Mariangela Monsalve
Documents
Files (1)
- Download
Contract - HT941026PE151.pdf
2.2 MBAdded in Award Notice version 3Posted
Lifecycle
- 3Version 3Award NoticeArchivedCurrent
SIRTEX SIR-Spheres Y-90 Microspheres
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
The VA Puget Sound Health Care System Pathology and Laboratory Medicine Service requires a histology staining workflow system which includes: Two (2) immunohistochemistry (IHC) and two (2) in-situ hybridization (ISH) immunostainers, and two (2) special stainers, and a specimen tracking system which promotes proper identification of specimens and slides and will audit workflow to identify areas that need improvement and reduce errors. The tracking system will improve patient safety, provide a chain of custody, and will monitor productivity. All the components of the workflow system must communicate with each other in order to track the workflow. The stainers attached to this system must be automated and allow the system to track and label slides for special staining and immunostaining. The workflow system must be compatible with the IT systems VISTA and/or Cerner, as well as any other new electronic health record system the VA acquires and also be compatible with Data Innovations middleware. | - | Market Research | 11/13/2026 |
Procurement of rapid syndromic molecular testing reagents for the Seattle VA Medical Center. Please see Attachments for further information in regards to this acquisition. | - | Market Research | 08/06/2027 |
This RFI does not commit the U.S. Government to issue a solicitation, make an award, or pay any costs associated with responding to this announcement. Item 0001: OXYGEN, USP, FILLED CYLINDER, SIZE D, 95GAL, TYPE I-DOT 3AA STEEL NSN: 6505-00-132-5181 Shall be made in accordance with MIL-O-37997 DATED 18 DECEMBER 1985 (attached) and changes listed in the attachment to this notice. Item 0002: OXYGEN, USP, FILLED CYLINDER, SIZE H, 1650 GAL, TYPE I-DOT 3AA STEEL NSN: 6505-00-132-5199 Shall be made in accordance with MIL-O-37997 DATED 18 DECEMBER 1985 (attached) and changes listed in the attachment to this notice. Item 0003: NITROUS OXIDE, USP, FILLED CYLINDER, SIZE D, 250 GAL, TYPE I-DOT 3AA STEEL NSN: 6505-00-130-1920 Shall be made in accordance with MIL-N-37996 DATED 24 DECEMBER 1985 (attached) and changes listed in the attachment to this notice. ----------------------------------------------------- The Defense Logistics Agency Troop Support is seeking sources capable of providing the Medical Gas Cylinder in accordance with the Military Specifications listed above. NOTE: Only Type I-DOT 3AA STEEL Medical Gas Cylinders are acceptable. If your firm currently manufactures or distributes Type I-DOT 3AA STEEL Medical Gas Cylinders in accordance with the Military Specifications and changes attached, please provide information with respect to the following: Source and Part Number being supplied for each type of cylinder Place of manufacture for each type of cylinder Source for the Medical Gases Current unit sale price for each type of cylinder prefilled with the medical grade gas Estimated annual capacity for each type of cylinder/medical grade gas Data obtained from this Request For Information (RFI) will be used by DLA Troop Support in making recommendations and decisions on the development of an appropriate planning and procurement strategy for the ATNAA. All information submitted shall remain with the U.S. Government and will not be returned. It will be kept confidential as allowed by relevant Federal law and will be eligible for additional special protections under the conditions of the Protected Critical Infrastructure Information (PCII) Program outlined in the Critical Infrastructure Information Act of 2002. Your response to this RFI may be submitted electronically via emailed to Jessica De La Hoz, Contracting Officer, Phone: 445-737-3623, Email: Jessica.DeLaHoz@dla.mil | - | Market Research | 11/15/2026 |
Please see attached for the sources sought notice/market research survey and MPID. | - | Market Research | 11/30/2026 |
The Department of War (DoW) is required by law (10 U.S.C. § 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoW Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoW Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry. The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and the Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the UF decision. This process is described in the attached RFQ. P&T COMMITTEE MEETING: The following November 2026 newly approved drugs will be reviewed: a. Adquey - Atopic - Subclass: Topical Agents b. Armlupeg - White Blood Cell Stimulants - Subclass: Pegfilgrastims c. Beqalzi - Oncological Agents - Non-BTKI for Chronic Lymphocytic Leukemia-Small Lymphocytic Lymphoma d. Bixlenvo - Antiretrovirals - Subclass: Combinations e. Clotic - Antifungals - Subclass: NA f. Etcamah - Breast Cancer Agents - Estrogen Receptor Antagonist g. Langlara - Insulins - Subclass: Basal h. Lisraya - Targeted Immunomodulatory Biologics – NA i. Mimrylo - Hematological Agents – NA j. Nuzolvence - Antibiotics – NA k. Rasonque - Oncological Agents - Subclass: RAS Inhibitors l. Rezenopy - Alcohol Deterrants - Narcotic Antagonists The RFQ, including UF BPA and UF ADP appendices are attached here in. The instructions, important deadlines, and points of contact are in document, RFQ HT9402-26-Q-9404. Pre-quotation teleconference is on October 14, 2026. Details are stated in Part 2.4. Pre-Quotation Teleconference. Responses to the clinical questions in Part 3.4 shall be submitted via e-mail to the RFQ POC in Part 2.3.1., no later than the date stated in Part 2.3.2. | - | Solicitation | 10/26/2026 |
Additional Details
Solicitation Number
HT941026PE151
Archive Date
Sep 3, 2026
Office Address
CAMP PENDLETON, CA, 92055